Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply.
作者信息
Colhoun Helen M, McGurnaghan Stuart J, McKeigue Paul M
机构信息
Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, EH4 2XU, UK; Public Health Scotland, Glasgow, UK.
Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, EH4 2XU, UK; Public Health Scotland, Glasgow, UK.
出版信息
Lancet Diabetes Endocrinol. 2021 Apr;9(4):201. doi: 10.1016/S2213-8587(21)00055-3.
Abstract
摘要
相似文献
1
Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply.糖尿病中的微血管疾病与严重的新冠病毒病结局——作者回复
Lancet Diabetes Endocrinol. 2021 Apr;9(4):201. doi: 10.1016/S2213-8587(21)00055-3.
2
Microvascular disease in diabetes and severe COVID-19 outcomes.糖尿病中的微血管疾病与严重的2019冠状病毒病结局
Lancet Diabetes Endocrinol. 2021 Apr;9(4):200-201. doi: 10.1016/S2213-8587(21)00053-X.
3
Observational research on severe COVID-19 in diabetes.糖尿病患者中重症新冠肺炎的观察性研究。
Lancet Diabetes Endocrinol. 2021 Feb;9(2):56-57. doi: 10.1016/S2213-8587(20)30432-0. Epub 2020 Dec 23.
4
Management of diabetes in patients with COVID-19 - Authors' reply.2019冠状病毒病患者的糖尿病管理——作者回复
Lancet Diabetes Endocrinol. 2020 Aug;8(8):669-670. doi: 10.1016/S2213-8587(20)30223-0.
5
Antihypertensive drugs and risk of COVID-19? - Authors' reply.抗高血压药物与2019冠状病毒病风险？——作者回复
Lancet Respir Med. 2020 May;8(5):e32-e33. doi: 10.1016/S2213-2600(20)30159-4. Epub 2020 Mar 26.
6
The ability of the neonatal immune response to handle SARS-CoV-2 infection - Authors' reply.新生儿免疫反应应对新型冠状病毒2感染的能力——作者回复
Lancet Child Adolesc Health. 2021 Mar;5(3):e8. doi: 10.1016/S2352-4642(21)00004-3. Epub 2021 Jan 21.
7
Risk factors for in-hospital mortality in patients with cancer and COVID-19 - Authors' reply.癌症合并新型冠状病毒肺炎患者院内死亡的危险因素——作者回复
Lancet Oncol. 2020 Sep;21(9):e408. doi: 10.1016/S1470-2045(20)30467-8.
8
Toward a clinically based classification of disease severity for paediatric COVID-19 - Authors' reply.关于儿童新型冠状病毒肺炎疾病严重程度基于临床的分类——作者回复
Lancet Infect Dis. 2021 Jan;21(1):22-23. doi: 10.1016/S1473-3099(20)30397-2. Epub 2020 May 15.
9
Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?对于新冠病毒疾病（COVID-19）的严重程度而言，新诊断出的糖尿病比已存在的糖尿病是更强的风险因素吗？
J Diabetes. 2021 Feb;13(2):177-178. doi: 10.1111/1753-0407.13125. Epub 2020 Nov 9.
10
Instrumental dead space in ventilator management - Authors' reply.呼吸机管理中的器械死腔——作者回复
Lancet Respir Med. 2021 Mar;9(3):e23. doi: 10.1016/S2213-2600(21)00015-1. Epub 2021 Jan 29.
Zotero 插件